Advertisement
U.S. markets close in 4 hours 49 minutes
Advertisement

Becton, Dickinson and Company (BDX)

NYSE - Nasdaq Real Time Price. Currency in USD
Visitors trend2W10W9M
233.55+0.01 (+0.01%)
As of 11:10AM EST. Market open.

  • Dividend

    BDX announced a cash dividend of 0.95 with an ex-date of Dec. 7, 2023

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close233.54
Open234.60
Bid233.54 x 800
Ask233.82 x 800
Day's Range232.81 - 234.60
52 Week Range228.62 - 287.32
Volume380,507
Avg. Volume1,398,412
Market Cap67.826B
Beta (5Y Monthly)0.51
PE Ratio (TTM)45.89
EPS (TTM)5.09
Earnings DateJan 31, 2024 - Feb 05, 2024
Forward Dividend & Yield3.80 (1.63%)
Ex-Dividend DateDec 07, 2023
1y Target Est279.69
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-5% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BDX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Becton, Dickinson and Company
    Analyst Report: Becton, Dickinson and CompanyBecton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
    Rating
    Fair Value
    Economic Moat
    29 days agoMorningstar
View more
  • Insider Monkey

    Dividend Aristocrats List: Top 25 Among Billionaires

    In this article, we will discuss top 25 dividend aristocrats among billionaires. You can skip our detailed analysis of dividend aristocrats and the performance of dividend growers in the past, and go directly to read Dividend Aristocrats List: Top 10 Among Billionaires. Investing in dividend stocks offers a distinct opportunity for investors seeking consistent income. […]

  • Reuters

    UPDATE 1-US FDA clears Becton's less-invasive blood collection device

    Becton Dickinson said on Thursday the U.S. Food and Drug Administration (FDA) cleared its finger-prick blood collection device that could provide a less-invasive option for some commonly ordered lab tests. The device, BD MiniDraw Collection System, can help collect blood samples from a patient's finger through a trained healthcare professional without the need to do it from a vein, the company said. The clearances include blood collection for commonly ordered lab tests such as for lipid panel and tests to diagnose and monitor a variety of chronic conditions from hypertension to high cholesterol, it said.

  • PR Newswire

    BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood collection device that obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests.